Susan W. Murley
Plus aucun poste en cours
Profil
Susan W.
Murley worked as a Principal at various companies including Sumitomo Pharma America, Aspect Medical Systems, BioSphere Medical, Akamai Technologies, Genaissance Pharmaceuticals, Idenix Pharmaceuticals LLC, Upromise, Mintera Corp., and First Marblehead Corp.
She also served as the Co-Managing Partner at Wilmer Cutler Pickering Hale & Dorr LLP from 1986 to 2024.
Murley received her undergraduate degree from Tufts University in 1981 and her graduate degree from the University of Virginia in 1986.
Anciens postes connus de Susan W. Murley
| Sociétés | Poste | Fin |
|---|---|---|
Wilmer Cutler Pickering Hale & Dorr LLP
 Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Directeur Général | 01/01/2024 |
Upromise, Inc.
 Upromise, Inc. Miscellaneous Commercial ServicesCommercial Services Upromise, Inc. engages in the provision of college savings plans and education programs while making everyday purchases in grocery and drug stores, gas stations, restaurants, hotels, and online shopping. The company was founded by Michael E. Bronner, Andre L. David, and Jeffrey J. Bussgang in 2000 and is headquartered in Newton, MA. | Corporate Officer/Principal | - |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | - |
Mintera Corp.
 Mintera Corp. Trucks/Construction/Farm MachineryProducer Manufacturing Mintera's world-class team has a strong track record in introducing leading edge products and satisfying customers in the most demanding environments. Mintera is backed by prestigious venture capital firms and is already serving the requirements of partners world-wide. Mintera's solutions enable easy deployment of next generation 40 Gbps optical transport in metro-core, regional, long- haul and ultra long-haul optical networks. With products ready for deployment today, it is the company to turn to when customers need help implementing 40 Gigabit per second (Gbps) solutions. Mintera's flexible multi-service 40 Gbps product-set, protected by multiple pending patents, enables service providers to seamlessly and cost effectively to upgrade their existing infrastructure to 40 Gbps in an evolutionary fashion and preserve existing investments by adding this capability to currently installed networks. | Corporate Officer/Principal | - |
| IDENIX PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Formation de Susan W. Murley
| University of Virginia | Graduate Degree |
| Tufts University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AKAMAI TECHNOLOGIES, INC. | Technology Services |
| Entreprise privées | 9 |
|---|---|
Wilmer Cutler Pickering Hale & Dorr LLP
Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Commercial Services |
Aspect Medical Systems, Inc.
 Aspect Medical Systems, Inc. Medical SpecialtiesHealth Technology Aspect Medical Systems, Inc. developed and manufactured anesthesia monitoring system that was called Bispectral (BIS) system. The company was founded in 1987 and was headquartered in Norwood, MA. | Health Technology |
BioSphere Medical, Inc.
 BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Health Technology |
First Marblehead Corp.
 First Marblehead Corp. Financial ConglomeratesFinance First Marblehead Corp. provides outsourcing services to national and regional financial and educational institutions for designing and implementing education loan programs. It helps education financing need by offering national and regional financial institutions and educational institutions the Monogram platform, an integrated suite of design, implementation and credit risk management services for private label, customizable private education loan programs. The firm also offers outsourced tuition planning, billing and payment technology services through its subsidiary Tuition Management Systems LLC. The company was founded by Daniel Maxwell Meyers and Stephen E. Anbinder in 1991 and is headquartered in Medford, MA. | Finance |
Genaissance Pharmaceuticals, Inc.
 Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Mintera Corp.
Mintera Corp. Trucks/Construction/Farm MachineryProducer Manufacturing Mintera's world-class team has a strong track record in introducing leading edge products and satisfying customers in the most demanding environments. Mintera is backed by prestigious venture capital firms and is already serving the requirements of partners world-wide. Mintera's solutions enable easy deployment of next generation 40 Gbps optical transport in metro-core, regional, long- haul and ultra long-haul optical networks. With products ready for deployment today, it is the company to turn to when customers need help implementing 40 Gigabit per second (Gbps) solutions. Mintera's flexible multi-service 40 Gbps product-set, protected by multiple pending patents, enables service providers to seamlessly and cost effectively to upgrade their existing infrastructure to 40 Gbps in an evolutionary fashion and preserve existing investments by adding this capability to currently installed networks. | Producer Manufacturing |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Upromise, Inc.
Upromise, Inc. Miscellaneous Commercial ServicesCommercial Services Upromise, Inc. engages in the provision of college savings plans and education programs while making everyday purchases in grocery and drug stores, gas stations, restaurants, hotels, and online shopping. The company was founded by Michael E. Bronner, Andre L. David, and Jeffrey J. Bussgang in 2000 and is headquartered in Newton, MA. | Commercial Services |